Literature DB >> 11568975

Characterization of a novel gene, STAG1/PMEPA1, upregulated in renal cell carcinoma and other solid tumors.

F K Rae1, J D Hooper, D L Nicol, J A Clements.   

Abstract

Using differential display-polymerase chain reaction, we identified a novel gene sequence, designated solid tumor-associated gene 1 (STAG1), that is upregulated in renal cell carcinoma (RCC). The full-length cDNA (4839 bp) encompassed the recently reported androgen-regulated prostatic cDNA PMEPA1, and so we refer to this gene as STAG1/PMEPA1. Two STAG1/PMEPA1 mRNA transcripts of approximately 2.7 and 5 kb, with identical coding regions but variant 3' untranslated regions, were predominantly expressed in normal prostate tissue and at lower levels in the ovary. The expression of this gene was upregulated in 87% of RCC samples and also was upregulated in stomach and rectal adenocarcinomas. In contrast, STAG1/PMEPA1 expression was barely detectable in leukemia and lymphoma samples. Analysis of expressed sequence tag databases showed that STAG1/PMEPA1 also was expressed in pancreatic, endometrial, and prostatic adenocarcinomas. The STAG1/PMEPA1 cDNA encodes a 287-amino-acid protein containing a putative transmembrane domain and motifs that suggest that it may bind src homology 3- and tryptophan tryptophan domain-containing proteins. This protein shows 67% identity to the protein encoded by the chromosome 18 open reading frame 1 gene. Translation of STAG1/PMEPA1 mRNA in vitro showed two products of 36 and 39 kDa, respectively, suggesting that translation may initiate at more than one site. Comparison to genomic clones showed that STAG1/PMEPA1 was located on chromosome 20q13 between microsatellite markers D20S183 and D20S173 and spanned four exons and three introns. The upregulation of this gene in several solid tumors indicated that it may play an important role in tumorigenesis. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568975     DOI: 10.1002/mc.1063

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  29 in total

1.  Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera.

Authors:  Zeyu Xiong; Yan Yan; Enli Liu; Richard T Silver; Srdan Verstovsek; Fan Yang; Hong Wang; Josef Prchal; Xiao-Feng Yang
Journal:  Clin Immunol       Date:  2006-11-17       Impact factor: 3.969

2.  Clinical Correlates of Autosomal Chromosomal Abnormalities in an Electronic Medical Record-Linked Genome-Wide Association Study: A Case Series.

Authors:  Hayan Jouni; Khader Shameer; Yan W Asmann; Ribhi Hazin; Mariza de Andrade; Iftikhar J Kullo
Journal:  J Investig Med       Date:  2013-10       Impact factor: 2.895

3.  2-(2-nitrobenzylidene) indolin-3-one compound inhibits transmembrane prostate androgen-induced protein (TMEPAI) expression and cancer cell proliferation.

Authors:  Yuyin Li; Jianjun Wang; Ning Song; Feihong Zeng; Miaomiao Zhao; Ali Wang; Yue Chen; Lei Jing; Peng Yu; Aipo Diao
Journal:  Cell Prolif       Date:  2018-08-02       Impact factor: 6.831

4.  The transmembrane protein TMEPAI induces myeloma cell apoptosis by promoting degradation of the c-Maf transcription factor.

Authors:  Yanyun Du; Yan Liu; Yujia Xu; Jiaxiang Juan; Zubin Zhang; Zhuan Xu; Biyin Cao; Qi Wang; Yuanying Zeng; Xinliang Mao
Journal:  J Biol Chem       Date:  2018-02-21       Impact factor: 5.157

5.  Identification of human gene products containing Pro-Pro-x-Tyr (PY) motifs that enhance glutathione and endocytotic marker uptake in yeast.

Authors:  Shujie Shi; Sylvia Notenboom; Mark E Dumont; Nazzareno Ballatori
Journal:  Cell Physiol Biochem       Date:  2010-01-12

6.  Transforming growth factor-beta (TGF-beta)-inducible gene TMEPAI converts TGF-beta from a tumor suppressor to a tumor promoter in breast cancer.

Authors:  Prajjal K Singha; I-Tien Yeh; Manjeri A Venkatachalam; Pothana Saikumar
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

7.  Development of Novel Monoclonal Antibodies for Evaluation of Transmembrane Prostate Androgen-Induced Protein 1 (TMEPAI) Expression Patterns in Gastric Cancer.

Authors:  Mikhail S Karbyshev; Evgeniya S Grigoryeva; Viktor V Volkomorov; Elisabeth Kremmer; Alexander Huber; Irina V Mitrofanova; Evgeniya V Kaigorodova; Marina V Zavyalova; Julia G Kzhyshkowska; Nadezda V Cherdyntseva; Evgeny L Choynzonov
Journal:  Pathol Oncol Res       Date:  2017-06-05       Impact factor: 3.201

8.  Requirement of TCF7L2 for TGF-beta-dependent transcriptional activation of the TMEPAI gene.

Authors:  Naoko Nakano; Susumu Itoh; Yukihide Watanabe; Kota Maeyama; Fumiko Itoh; Mitsuyasu Kato
Journal:  J Biol Chem       Date:  2010-09-30       Impact factor: 5.157

9.  Circulating Tumor Cell-Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue-Based Messenger RNA Profiling Into a Noninvasive Setting.

Authors:  Yi-Te Lee; Na Sun; Minhyung Kim; Jasmine J Wang; Benjamin V Tran; Ryan Y Zhang; Dongping Qi; Ceng Zhang; Pin-Jung Chen; Saeed Sadeghi; Richard S Finn; Sammy Saab; Steven-Huy B Han; Ronald W Busuttil; Renjun Pei; Yazhen Zhu; Hsian-Rong Tseng; Sungyong You; Ju Dong Yang; Vatche G Agopian
Journal:  Liver Transpl       Date:  2021-11-16       Impact factor: 5.799

10.  Sp1 transcription factor promotes TMEPAI gene expression and contributes to cell proliferation.

Authors:  Yuyin Li; Ailong Guo; Yajuan Feng; Yueying Zhang; Jianjun Wang; Lifang Jing; Yali Yan; Lei Jing; Zhenxing Liu; Long Ma; Aipo Diao
Journal:  Cell Prolif       Date:  2016-09-14       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.